Phoreus Biotech Raises $2 Million in Seed Round for Development of New Genetic Vaccines and Therapeutics
OLATHE, KS, Dec. 20, 2022 – Phoreus Biotechnology, a leading provider of next-generation peptide nanocarriers, announced today they have oversubscribed their $2 million dollar seed raise by more than 10 percent. Phoreus Biotech was founded…
View news